Clinical Trial Update: A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pregabalin plus PF-00489791 versus pregabalin alone in postherpetic neuralgia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• PF-00489791 (PF-00489791)
• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED | Results posted: 2021-08-05